{"abstract": "Johnson & Johnson announced late Thursday that it had agreed to buy Cougar Biotechnology for about $1 billion, or $43 a share in cash, in a move aimed at strengthening its position in the cancer drug market.", "web_url": "https://dealbook.nytimes.com/2009/05/21/johnson-johnson-to-buy-cougar-biotech/", "snippet": "Johnson & Johnson announced late Thursday that it had agreed to buy Cougar Biotechnology for about $1 billion, or $43 a share in cash, in a move aimed at strengthening its position in the cancer drug market.", "lead_paragraph": "Johnson & Johnson announced late Thursday that it had agreed to buy Cougar Biotechnology for about $1 billion, or $43 a share in cash, in a move aimed at strengthening its position in the cancer drug market.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson to Buy Cougar Biotech", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-05-22T00:13:34+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/67852622-e085-59bb-983a-fd6a9bb319be", "word_count": 219, "uri": "nyt://article/67852622-e085-59bb-983a-fd6a9bb319be"}